KMED KraneShares Emerging Mkts Hlthcare ETF
Solactive EM Healthcare NR USD

NAV as of 30-Nov-2022

21.7400

4 Week: 20.82 - 22.25

52 Week: 19.01 - 28.63

Latest Closing Price

21.87

Premium / Discount

1.51

Expense Ratio

0.81%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the Solactive Emerging Markets Healthcare Index (the index). The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
KraneShares
Asset Under Management:
2,186,756
Launch Date:
28/08/2018
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
95
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
Emerging Markets / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-21.421.50-14.29
1 Day-0.900.000.00
1 Week3.063.051.00
1 Month6.056.820.89
3 Months1.7912.730.14
6 Months1.2016.320.07
1 Year-22.3123.07-0.97
2 Years-33.5331.38-1.07
3 Years1.8143.450.04
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.000012.308359.4163-21.7878
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.000086.00002.000099.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 95

Number of Bond Holdings: 0

Number of Equity Holdings: 90

Total Market Value: 2,186,756

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Samsung BioLogics Co Ltd4.84141850136,642

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant36.40
Large48.73
Medium12.69
Small2.18
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

26.5179

Price/Book*

3.2772

Price/Sales*

3.4705

Price/Cash Flow*

17.8061

Dividend Yield*

1.2010

Growth Measures

Long-Term Earnings

17.0833

Historical Earnings

16.1965

Sales Growth

17.8549

Cash-Flow Growth

29.2113

Book-Value Growth

15.0097

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.